1. Home
  2. MIR vs CNS Comparison

MIR vs CNS Comparison

Compare MIR & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIR
  • CNS
  • Stock Information
  • Founded
  • MIR 2005
  • CNS 1986
  • Country
  • MIR United States
  • CNS United States
  • Employees
  • MIR N/A
  • CNS N/A
  • Industry
  • MIR Industrial Machinery/Components
  • CNS Investment Managers
  • Sector
  • MIR Technology
  • CNS Finance
  • Exchange
  • MIR Nasdaq
  • CNS Nasdaq
  • Market Cap
  • MIR 4.1B
  • CNS 4.7B
  • IPO Year
  • MIR N/A
  • CNS 2004
  • Fundamental
  • Price
  • MIR $15.56
  • CNS $88.47
  • Analyst Decision
  • MIR Strong Buy
  • CNS Hold
  • Analyst Count
  • MIR 4
  • CNS 3
  • Target Price
  • MIR $19.25
  • CNS $92.00
  • AVG Volume (30 Days)
  • MIR 2.0M
  • CNS 192.3K
  • Earning Date
  • MIR 02-11-2025
  • CNS 01-22-2025
  • Dividend Yield
  • MIR N/A
  • CNS 2.65%
  • EPS Growth
  • MIR N/A
  • CNS 14.23
  • EPS
  • MIR N/A
  • CNS 2.97
  • Revenue
  • MIR $836,900,000.00
  • CNS $517,417,000.00
  • Revenue This Year
  • MIR $7.38
  • CNS $14.99
  • Revenue Next Year
  • MIR $5.59
  • CNS $7.56
  • P/E Ratio
  • MIR N/A
  • CNS $29.81
  • Revenue Growth
  • MIR 6.15
  • CNS 5.67
  • 52 Week Low
  • MIR $9.11
  • CNS $64.13
  • 52 Week High
  • MIR $18.81
  • CNS $110.67
  • Technical
  • Relative Strength Index (RSI)
  • MIR 42.25
  • CNS 42.75
  • Support Level
  • MIR $14.43
  • CNS $84.31
  • Resistance Level
  • MIR $18.45
  • CNS $91.07
  • Average True Range (ATR)
  • MIR 0.71
  • CNS 2.34
  • MACD
  • MIR -0.19
  • CNS 0.56
  • Stochastic Oscillator
  • MIR 28.11
  • CNS 68.31

About MIR Mirion Technologies Inc.

Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Technologies. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Technologies segment is based around the nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. It derives maximum revenue from Technologies Segment.

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for close to two thirds of its $79.3 billion in managed assets at the end of January 2024. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 42% (27%) of its managed assets (base management fees) from institutional clients, 45% (52%) from open-end funds, and 13% (21%) from closed-end funds.

Share on Social Networks: